Arcapta Neohaler is a prescription inhaler that can be used for the long-term management of symptoms ofChronic Obstructive Pulmonary Disease (COPD). COPD includes the conditions chronic bronchitis and emphysema. Arcapta Neohaler is a long-acting beta-agonist (LABA) that expands the lungs for easier oxygen and carbon dioxide (gas exchange). LABA medications work by relaxing the smooth muscles of the lungs. Arcapta is no longer available for purchase in pharmacies in the United States. Fact Table Formula C24H28N2O3 License US FDA, EU EMA Bioavailability 43-45% Legal status Rx-only Chemical Name Indacaterol Elimination half-life More than 30 h Dosage (Strength) 75mcg Pregnancy Consult Doctor Brands Onbrez, Arcapta Protein binding 94.1-95.3% PubChem CID 6433117 MedlinePlus a612014 ChEBI 68575 ATC code R03AC18 DrugBank DB05039 KEGG D09318 Routes of administration Inhalation